Selective inhibitors of nuclear export (SINE)- a novel class of anti-cancer agents

被引：113

作者：

Parikh, Kaushal ^{[1
,2
]}

Cang, Shundong ^{[3
]}

Sekhri, Arunabh ^{[1
,2
]}

Liu, Delong ^{[4
]}

机构：

[1] New York Med Coll, Dept Med, Valhalla, NY 10595 USA

[2] Westchester Med Ctr, Valhalla, NY 10595 USA

[3] Peoples Hosp Henan Prov, Dept Oncol, Zhengzhou, Peoples R China

[4] Zhengzhou Univ, Henan Tumor Hosp, Zhengzhou 450052, Peoples R China

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2014年 / 7卷

关键词：

SINE; KPT-330; Selinexor; Nuclear export; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR SIGNALING PATHWAY; CELL LUNG-CANCER; IMPROVED SURVIVAL; DRUG-RESISTANCE; CRM1; INHIBITOR; C/EBP-ALPHA; EGFR-TKIS; APOPTOSIS;

D O I：

10.1186/s13045-014-0078-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Dysregulation of the nucleo-cytoplasmic transport of proteins plays an important role in carcinogenesis. The nuclear export of proteins depends on the activity of transport proteins, exportins. Exportins belong to the karyopherin beta superfamily. Exportin-1 (XPO1), also known as chromosomal region maintenance 1 (CRM1), mediates transport of around 220 proteins. In this review, we summarized the development of a new class of antitumor drugs, collectively known as selective inhibitors of nuclear export (SINE). KPT-330 (selinexor) as an oral agent is showing activities in early clinical trials in both solid tumors and hematological malignancies.

引用

页数：8

共 50 条

[1] Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
Kaushal Parikh
Shundong Cang
Arunabh Sekhri
Delong Liu
Journal of Hematology & Oncology, 7
[2] SINE (selective inhibitor of nuclear export) – translational science in a new class of anti-cancer agents
John Gerecitano
Journal of Hematology & Oncology, 7
[3] SINE (selective inhibitor of nuclear export) - translational science in a new class of anti-cancer agents
Gerecitano, John
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
[4] Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer
Mendonca, Janet
Sharma, Anup
Kim, Hae-Soo
Hammers, Hans
Meeker, Alan
De Marzo, Angelo
Carducci, Michael
Kauffman, Michael
Shacham, Sharon
Kachhap, Sushant
ONCOTARGET, 2014, 5 (15) : 6102 - 6112
[5] mTOR inhibitors: A novel class of anti-cancer agents
Haris Riaz
Talha Riaz
Syed A Hussain
Infectious Agents and Cancer, 7
[6] mTOR inhibitors: A novel class of anti-cancer agents
Riaz, Haris
Riaz, Talha
Hussain, Syed A.
INFECTIOUS AGENTS AND CANCER, 2012, 7
[7] Selective Inhibitors of Nuclear Export (SINE) for Gemcitabine Resistant Pancreatic Cancer
Azmi, A. S.
Kauffman, M.
Shacham, S.
Mohammad, R. M.
PANCREAS, 2013, 42 (08) : 1338 - 1338
[8] Selective inhibitors of nuclear export (SINE) in hematological malignancies
Das A.
Wei G.
Parikh K.
Liu D.
Experimental Hematology & Oncology, 4 (1)
[9] Mitotic kinesin inhibitors as novel anti-cancer agents
Wood, KW
Bergnes, G
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 39, 2004, 39 : 173 - 183
[10] Phosphatidylserine Selective Peptides As Novel Anti-cancer Agents
Manavbasi, Yasemin
Zweytick, Dagmar
Willumeit, Regine
Lohner, Karl
BIOPHYSICAL JOURNAL, 2009, 96 (03) : 157A - 157A

← 1 2 3 4 5 →